Bio Gene (Australia) Market Value
| BGT Stock | 0.04 0 2.33% |
| Symbol | Bio |
Bio Gene 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bio Gene's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bio Gene.
| 12/13/2022 |
| 12/02/2024 |
If you would invest 0.00 in Bio Gene on December 13, 2022 and sell it all today you would earn a total of 0.00 from holding Bio Gene Technology or generate 0.0% return on investment in Bio Gene over 720 days. Bio Gene is related to or competes with Northern Star, Evolution Mining, Bluescope Steel, and Aneka Tambang. Bio Gene is entity of Australia. It is traded as Stock on AU exchange. More
Bio Gene Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bio Gene's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bio Gene Technology upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.12 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 22.66 | |||
| Value At Risk | (7.27) | |||
| Potential Upside | 7.41 |
Bio Gene Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bio Gene's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bio Gene's standard deviation. In reality, there are many statistical measures that can use Bio Gene historical prices to predict the future Bio Gene's volatility.| Risk Adjusted Performance | 0.0239 | |||
| Jensen Alpha | 0.0398 | |||
| Total Risk Alpha | (0.62) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.2684 |
Bio Gene Technology Backtested Returns
Currently, Bio Gene Technology is out of control. Bio Gene Technology secures Sharpe Ratio (or Efficiency) of 0.0124, which signifies that the company had a 0.0124% return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Bio Gene Technology, which you can use to evaluate the volatility of the firm. Please confirm Bio Gene's Mean Deviation of 2.35, risk adjusted performance of 0.0239, and Downside Deviation of 6.12 to double-check if the risk estimate we provide is consistent with the expected return of 0.0523%. The firm shows a Beta (market volatility) of 0.28, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Bio Gene's returns are expected to increase less than the market. However, during the bear market, the loss of holding Bio Gene is expected to be smaller as well. Bio Gene Technology right now shows a risk of 4.21%. Please confirm Bio Gene Technology information ratio, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to decide if Bio Gene Technology will be following its price patterns.
Auto-correlation | 0.38 |
Below average predictability
Bio Gene Technology has below average predictability. Overlapping area represents the amount of predictability between Bio Gene time series from 13th of December 2022 to 8th of December 2023 and 8th of December 2023 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bio Gene Technology price movement. The serial correlation of 0.38 indicates that just about 38.0% of current Bio Gene price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.38 | |
| Spearman Rank Test | 0.38 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Bio Gene Technology lagged returns against current returns
Autocorrelation, which is Bio Gene stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bio Gene's stock expected returns. We can calculate the autocorrelation of Bio Gene returns to help us make a trade decision. For example, suppose you find that Bio Gene has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Bio Gene regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bio Gene stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bio Gene stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bio Gene stock over time.
Current vs Lagged Prices |
| Timeline |
Bio Gene Lagged Returns
When evaluating Bio Gene's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bio Gene stock have on its future price. Bio Gene autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bio Gene autocorrelation shows the relationship between Bio Gene stock current value and its past values and can show if there is a momentum factor associated with investing in Bio Gene Technology.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Bio Stock Analysis
When running Bio Gene's price analysis, check to measure Bio Gene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Gene is operating at the current time. Most of Bio Gene's value examination focuses on studying past and present price action to predict the probability of Bio Gene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Gene's price. Additionally, you may evaluate how the addition of Bio Gene to your portfolios can decrease your overall portfolio volatility.